Claudio Nicotra

Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial

Loïc Verlingue, David Malka, Adrien Allorant et al. · European Journal of Cancer · 2017 · 170 citations

Medicine, Oncology, Surgery +11

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer

Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti et al. · Clinical Cancer Research · 2019 · 167 citations · Full text

Medicine, Oncology, Pharmacology +16

Osimertinib benefit inEGFR-mutant NSCLC patients withT790M-mutation detected by circulating tumour DNA

Jordi Remón, Caroline Caramella, Cécile Jovelet et al. · Annals of Oncology · 2017 · 164 citations

Medicine, Genetics, Oncology +12

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

David Tamborero, Rodrigo Dienstmann, Maan Haj Rachid et al. · Nature Cancer · 2022 · 130 citations · Full text

Medicine, Biomedical Informatics, Oncology +17

Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in <i>ALK</i> -Rearranged Non–Small-Cell Lung Cancer

Emma Pailler, Vincent Faugeroux, Marianne Oulhen et al. · Clinical Cancer Research · 2019 · 117 citations · Full text

Medicine, Molecular Medicine, Oncology +17